In this COVID-19 clinical update, Daniel Griffin summarizes current status of vaccination in the US, discusses a study on convalescent sera from Argentina, use of remdesivir in patients with kidney disease, and provides further considerations on the use of Ct values in patient management.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

Argentine study on plasma therapy (NEJM)
Ct values and clinical outcome (Open Forum Inf Dis)
Bamlanivimab fact sheet (FDA pdf)
Cognitive defects in recovered COVID-19 patients (medRxiv)
Letters read on TWiV 704
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

TWiV 704: COVID-19 clinical update #44 with Dr. Daniel Griffin